Nanoparticles | CHOP Research Institute
 

Nanoparticles

What Affects How Nanoparticles Interact With Our Immune System?

Published on
Feb 7, 2022
in Cornerstone Blog
Snapshot Science: What Affects How Nanoparticles Interact With Our Immune System?
New research describes a nanomaterial property that dictates how particles interact with “first-responder” immune cells, neutrophils.

Improving Outcomes in Pediatric Oncology: Q&A With Garrett Brodeur, MD

Published on
Jan 3, 2022
in Cornerstone Blog
Improving Outcomes in Pediatric Oncology
Congratulations to Garrett Brodeur, MD, recipient of the American Society of Pediatric Hematology/Oncology Distinguished Career Award.

Brodeur Laboratory

Brodeur Lab

Research in the Brodeur Lab focuses on two main areas: nanoparticle drug delivery and cancer predisposition. Nanomedicines allow the delivery of much more drug to the tumor and much less to the patient.

Garrett M. Brodeur, MD
Garrett M. Brodeur

Dr. Broedur’s research interests focus on nanoparticle drug delivery and cancer predisposition. He is also interested in identifying novel cancer predisposition genes, and developing enhanced surveillance techniques to identify cancer early in predisposed individuals with the hope of improving outcome and reducing side effects.

E-mail:
brodeur [at] chop.edu

Neuroblastoma Studies Show Promise of Nanoparticles in Fighting Tumors

Published on
Jun 1, 2015
in Cornerstone Blog
Researchers from CHOP are exploring how biodegradable nanoparticles can precisely deliver anticancer drugs to attack neuroblastoma, an often-deadly children’s cancer.

Biodegradable Nanoparticles May Hold Therapeutic Use

Published on
Aug 7, 2014
in Cornerstone Blog
CHOP has long investigated biodegradable nanoparticles for medical use. With diameters ranging from a few tens to a few hundreds of nanometers, these particles are 10 to 1000 times smaller than red blood cells.